bookmark icon

The U.S. Food & Drug Administration has not yet authorized COVID-19 vaccine booster doses, and CDC’s Advisory Committee on Immunization Practices (ACIP) has not yet made a recommendation on booster doses for people living and working in LTC settings. CDC will update this webpage when new information is available.

COVID-19 Vaccine Access in Long-term Care Settings

Illustration of health care providers wearing masks

The federal government is committed to ensuring that residents and staff in long-term care (LTC) settings, such as nursing homes, assisted living, residential care communities, group homes and senior housing have access to COVID-19 vaccines to receive primary series and booster doses (if approved by the US Food and Drug Administration [FDA] and recommended by CDC’s Advisory Committee on Immunization Practices [ACIP]).

The goal is to continue to protect those who are disproportionately affected by COVID-19—especially residents of LTC settings. All LTC settings that request assistance in accessing COVID-19 vaccines for their residents and staff will receive the support they need.

Many LTC providers have already identified strategies and partnerships to obtain and administer COVID-19 vaccines for residents and staff. These include:

  • Working with established LTC partners and retail pharmacy partners
  • Coordinating with state and local health departments

Long-term care providers are encouraged to consider the option that works best for their residents and staff when coordinating access to COVID-19 vaccines, either in the local community or on-site. Additional details on these options are available on the pages linked below.

Additional Information: COVID-19 Vaccination Recommendations

COVID-19 vaccination is recommended for all people aged 12 years and older in the United States for the prevention of COVID-19.  COVID-19 vaccines currently approved or authorized by FDA are highly effective in preventing serious outcomes of COVID-19, including severe disease, hospitalization, and death. Efforts to maximize the proportion of people in the United States who are fully vaccinated against COVID-19 remain critical to ending the COVID-19 pandemic. At present, people with moderately to severely compromised immune systems should receive an additional dose of mRNA COVID-19 vaccine after the initial 2 doses. If the FDA authorizes and ACIP recommends a booster dose, people who were first to receive a COVID-19 vaccination when they became available in early 2021 (e.g., those who are most at risk) are likely to be the first people eligible for a booster dose. This includes healthcare providers, LTC residents, and other older adults. For more information, visit COVID-19 Vaccine Booster Shot.

COVID-19 vaccines may now be administered without regard to timing of other vaccines. This includes simultaneous administration of COVID-19 vaccine and other vaccines on the same day, as well as coadministration within 14 days. See Interim Clinical Considerations for Use of COVID-19 Vaccines | CDC.

bookmark icon

If CDC’s ACIP makes a recommendation on booster doses for people living and working in LTC settings, CDC will update this webpage with more information when it is available.

Page last reviewed: September 17, 2021